Conditioning Regimens
|
Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer
|
123
|
S Bilgrami, JM Feingold, RD Bona, RL Edwards, AM Khan, F Rodriguez-Pinero, IA Khan, D Kazierad, J Clive & PJ Tutschka
|
Abstract Full Article PDF
|
 |
|
Non-Myeloablative Stem Cell Transplants
|
Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases
|
131
|
D Gómez-Almaguer, GJ Ruiz-Argüelles, A Ruiz-Argüelles, O González-Llano, OE Cantú & NE Hernández
|
Abstract Full Article PDF
|
 |
|
Immunobiology
|
Evidence of alloreactive T lymphocytes in fetal liver: implications for fetal hematopoietic stem cell transplantation
|
135
|
MC Renda, E Fecarotta, F Dieli, L Markling, M Westgren, G Damiani, C Jakil, F Picciotto & A Maggio
|
Abstract Full Article PDF
|
 |
|
Chronic Myeloid Leukaemia
|
Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemia
|
143
|
P Konstantinidou, RM Szydlo, A Chase & JM Goldman
|
Abstract Full Article PDF
|
 |
|
Infections Post-Transplant
|
Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation
|
147
|
D Kapur, D Dorsky, JM Feingold, RD Bona, RL Edwards, J Aslanzadeh, PJ Tutschka & S Bilgrami
|
Abstract Full Article PDF
|
 |
|
Viral Infections
|
Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients
|
153
|
RA Vescio, CH Wu, L Zheng, D Sheen, H Ma, J Liu, AK Stewart, O Ballester, SJ Noga, H Rugo, C Freytes, E Stadtmauer, F Sahebi, S Tarantolo, P Stiff, GJ Schiller, M White, C Jacobs, J DiPersio, KC Anderson & JR Berenson
|
Abstract Full Article PDF
|
 |
Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation a compassionate use experience
|
161
|
JP DeVincenzo, RL Hirsch, RJ Fuentes & FH Top Jr
|
Abstract Full Article PDF
|
 |
Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation
|
167
|
TF Leung, KW Chik, CK Li, H Lai, MMK Shing, PKS Chan, V Lee & PMP Yuen
|
Abstract Full Article PDF
|
 |
|
Post-Transplant Complications
|
Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy
|
173
|
PF Ferrucci, A Martinoni, E Cocorocchio, M Civelli, S Cinieri, D Cardinale, FA Peccatori, G Lamantia, A Agazzi, C Corsini, F Tealdo, C Fiorentini, CM Cipolla & G Martinelli
|
Abstract Full Article PDF
|
 |
Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation
|
179
|
J-H Lee, K-H Lee, S Kim, J-S Lee, S-H Kim, S-W Kwon & W-K Kim
|
Abstract Full Article PDF
|
 |
Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation
|
185
|
M Ando, T Yokozawa, J Sawada, Y Takaue, K Togitani, N Kawahigashi, M Narabayashi, K Takeyama, R Tanosaki, S Mineishi, Y Kobayashi, T Watanabe, I Adachi & K Tobinai
|
Abstract Full Article PDF
|
 |
|
Late Complications Post-SCT
|
Bone mass after allogeneic BMT for childhood leukaemia or lymphoma
|
191
|
K Nysom, K Holm, K Fleischer Michaelsen, H Hertz, N Jacobsen, J Müller & C Mølgaard
|
Abstract Full Article PDF
|
 |
|
Technical Report
|
Evaluation of optimal survival of primitive progenitor cells (LTC-IC) from PBPC apheresis products after overnight storage
|
197
|
AL Petzer, E Gunsilius, N Zech, J Clausen, E Hoflehner, W Nussbaumer & G Gastl
|
Abstract Full Article PDF
|
 |
|
Case Reports
|
Busulfan clearance in renal failure and hemodialysis
|
201
|
LL Ullery, JP Gibbs, GW Ames, FM Senecal & JT Slattery
|
Abstract Full Article PDF
|
 |
Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy
|
205
|
WYK Hwang, YT Goh, CH Tan, GF How & HCP Tan
|
Abstract Full Article PDF
|
 |
EpsteinBarr virus-associated lymphoproliferative disease after a cord blood transplant for DiamondBlackfan anemia
|
209
|
S Ohga, Y Kanaya, H Maki, H Takada, K Ohshima, M Kanda, A Nomura, A Suminoe, A Matsuzaki & T Hara
|
Abstract Full Article PDF
|
 |
A successful cord blood transplant in a child with second accelerated phase chronic myeloid leukemia following lymphoid blast crisis
|
213
|
AA Maschan, EV Skorobogatova, EV Samotchatova, DN Balashov, MI Yourlova, NI Bogatcheva, ED Pashanov, PE Trakhtman, AM Timakov & AG Rumiantzev
|
Abstract Full Article PDF
|
 |
Allogeneic peripheral blood cell transplantation for hypereosinophilic syndrome with myelofibrosis
|
217
|
L Vazquez, D Caballero, C Del Cañizo, C Lopez, R Hernandez, I Gonzalez, T Flores & JF San Miguel
|
Abstract Full Article PDF
|
 |
Successful treatment of relapsed CML after cord blood transplantation with donor leukocyte infusion IL-2 and IFN
|
219
|
HJ Laws, W Nürnberger, D Körholz, G Kögler, J Fischer, T Niehues, P Wernet & U Göbel
|
Abstract Full Article PDF
|
 |
|
Correspondence
|
Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases
|
223
|
A Schulenburg, P Kalhs, N Worel, P Höcker, P Knöbl & HT Greinix
|
Full Article PDF
|
 |
Late-onset herpes simplex virus-associated interstitial pneumonia after allogeneic bone marrow transplantation
|
225
|
A Kitabayashi, M Hirokawa, T Horiuchi, Y Kawabata & AB Miura
|
Full Article PDF
|
 |
Extramedullary relapse in the so-called 'sanctuary' sites for chemotherapy after donor lymphocyte infusion
|
226
|
S Seo, M Kami, H Honda, T Kashima, T Matsumura, A Moriya, U Machida, Y Kanda, S Chiba & H Hirai
|
Full Article PDF
|
 |
Establishing a BMT support group
|
227
|
DI Marks & K Benjamin
|
Full Article PDF
|
 |
Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration
|
228
|
C Kawano, K Muroi, R Kuribara, Y Matsumoto, T Ohtsuki & K Hatake
|
Full Article PDF
|
 |
 |
 |